Institutional Ownership Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX). We have compiled data on the 326 institutions that hold shares in the stock, with a total of 94.6 Million shares, which have been reported (via 13F filing form) to have a value of $2.05 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
18,694,918
shares
|
$385 Million
0.01% of portfolio
|
Q2 2024
Added 5.43%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
8,040,978
shares
|
$166 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.73%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
6,229,634
shares
|
$128 Million
2.3% of portfolio
|
Q3 2024
Reduced 31.75%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
5,685,330
shares
|
$117 Million
0.0% of portfolio
|
Q3 2024
Reduced 5.77%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
3,018,789
shares
|
$62.2 Million
0.01% of portfolio
|
Q3 2024
Added 0.6%
|
|
|
Pacer Advisors, Inc.
Malvern, PA |
Nov 12, 2024 Q3 2024 |
2,804,013
shares
|
$57.8 Million
0.13% of portfolio
|
Q3 2024
Reduced 5.51%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,664,424
shares
|
$54.9 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.27%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
2,526,016
shares
|
$52 Million
0.08% of portfolio
|
Q3 2024
Added 16.1%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Nov 13, 2024 Q3 2024 |
2,428,973
shares
|
$50 Million
0.05% of portfolio
|
Q3 2024
Reduced 1.78%
|
|
|
Royce & Associates LP
|
Nov 06, 2024 Q3 2024 |
2,021,105
shares
|
$41.6 Million
0.38% of portfolio
|
Q3 2024
Reduced 6.52%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,823,274
shares
|
$37.6 Million
0.0% of portfolio
|
Q3 2024
Added 80.04%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
1,472,253
shares
|
$30.3 Million
0.0% of portfolio
|
Q3 2024
Added 35.3%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
1,383,800
shares
|
$28.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.21%
|
|
|
Boston Partners
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,275,267
shares
|
$26.3 Million
0.03% of portfolio
|
Q3 2024
Reduced 9.32%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,234,383
shares
|
$25.4 Million
0.0% of portfolio
|
Q3 2024
Added 0.12%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
1,167,743
shares
|
$24.1 Million
0.0% of portfolio
|
Q3 2024
Added 4.55%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
1,139,142
shares
|
$23.5 Million
0.01% of portfolio
|
Q3 2024
Added 37.15%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
1,057,390
shares
|
$21.8 Million
0.09% of portfolio
|
Q3 2024
Reduced 21.18%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Nov 14, 2024 Q3 2024 |
1,041,416
shares
|
$21.5 Million
0.48% of portfolio
|
Q3 2024
Reduced 18.4%
|
|
|
Lsv Asset Management
Chicago, IL |
Nov 12, 2024 Q3 2024 |
951,324
shares
|
$19.6 Million
0.04% of portfolio
|
Q3 2024
Added 8.86%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
939,526
shares
|
$19.4 Million
0.0% of portfolio
|
Q3 2024
Added 11.92%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
860,934
shares
|
$17.7 Million
0.02% of portfolio
|
Q3 2024
Reduced 29.4%
|
|
|
Mesirow Institutional Investment Management, Inc.
Chicago, IL |
Nov 13, 2024 Q3 2024 |
800,798
shares
|
$16.5 Million
1.26% of portfolio
|
Q3 2024
Reduced 14.28%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2024 Q3 2024 |
767,229
shares
|
$15.8 Million
0.06% of portfolio
|
Q3 2024
Added 1.66%
|
|
|
Jupiter Asset Management LTD
|
Nov 12, 2024 Q3 2024 |
699,944
shares
|
$14.4 Million
0.13% of portfolio
|
Q3 2024
Reduced 5.63%
|